Botulinum toxin injections for the treatment of spasmodic dysphonia
about
Diagnosis and treatment of dystoniaDoes treatment of the laryngeal mucosa reduce dystonic symptoms? A prospective clinical cohort study of mannose binding lectin and other immunological parameters with diagnostic use of phonatory function studies.Clinical practice guideline: hoarseness (dysphonia).The focal dystonias: current views and challenges for future research
P2860
Botulinum toxin injections for the treatment of spasmodic dysphonia
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Botulinum toxin injections for the treatment of spasmodic dysphonia
@ast
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en-gb
Botulinum toxin injections for the treatment of spasmodic dysphonia
@nl
type
label
Botulinum toxin injections for the treatment of spasmodic dysphonia
@ast
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en-gb
Botulinum toxin injections for the treatment of spasmodic dysphonia
@nl
prefLabel
Botulinum toxin injections for the treatment of spasmodic dysphonia
@ast
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en-gb
Botulinum toxin injections for the treatment of spasmodic dysphonia
@nl
P2093
P2860
P1476
Botulinum toxin injections for the treatment of spasmodic dysphonia
@en
P2093
Christopher Watts
Renata Whurr
P2860
P356
10.1002/14651858.CD004327.PUB2
P577
2004-07-19T00:00:00Z